Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Domagala-Kulawik, J.
Right arrow Articles by Chazan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Domagala-Kulawik, J.
Right arrow Articles by Chazan, R.
(Chest. 2003;123:1054-1059.)
© 2003 American College of Chest Physicians

The Cellular Composition and Macrophage Phenotype in Induced Sputum in Smokers and Ex-Smokers With COPD*

Joanna Domagala-Kulawik, MD, PhD; Marta Maskey-Warzechowska, MD; Izabela Kraszewska, MS and Ryszarda Chazan, MD, PhD, FCCP

* From the Department of Pneumonology and Allergology, Warsaw Medical University, Warsaw, Poland.

Correspondence to: Joanna Domagala-Kulawik, MD, PhD, Department of Pneumonology and Allergology, ul Banacha 1a, 02 097 Warsaw, Poland; e-mail: jokula{at}amwaw.edu.pl

Study objectives: The relationship between smoking and COPD has been well-documented. We investigated the impact of cigarette smoking on airway inflammation in COPD patients.

Design: Changes in cell profiles in induced sputum (IS) samples from smokers with COPD and patients who ceased smoking were compared.

Setting: Department of pneumonology in a university hospital.

Patients: IS samples were collected from 17 smokers and 17 ex-smokers with COPD.

Interventions: We examined IS samples for differential cell counts and macrophage phenotypes determined by immunocytochemistry with monoclonal antibodies anti-CD11b, anti-CD14, anti-CD54, and anti-CD71.

Measurements and results: The median IS volume was greater and the total cell count was higher in smokers than in ex-smokers. The difference, however, was not significant. We did not find any significant differences in the proportions of cells and in the phenotypes of macrophages between the two groups, with the proportion of eosinophils being slightly higher in the group of smokers. We found, however, a significant positive correlation between the decrease in pulmonary function parameters and the number of pack-years smoked, an inverse correlation of pulmonary function test results with the number of lymphocytes in IS, and a correlation between some changes in the expression of macrophage surface markers and smoking history. There was no correlation between the time from smoking cessation and any cellular component found in IS samples.

Conclusions: The analysis of IS samples in patients with COPD revealed no significant differences in cell count and macrophage phenotypes between active smokers and ex-smokers.

Key Words: COPD • ex-smokers • induced sputum • macrophages • smokers




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Chaudhuri, E. Livingston, A. D. McMahon, J. Lafferty, I. Fraser, M. Spears, C. P. McSharry, and N. C. Thomson
Effects of Smoking Cessation on Lung Function and Airway Inflammation in Smokers with Asthma
Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R O'Donnell, D Breen, S Wilson, and R Djukanovic
Inflammatory cells in the airways in COPD
Thorax, May 1, 2006; 61(5): 448 - 454.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. F. M. Wouters
Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Hodge, G. Hodge, M. Holmes, and P. N. Reynolds
Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation
Eur. Respir. J., March 1, 2005; 25(3): 447 - 454.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N.C. Thomson, R. Chaudhuri, and E. Livingston
Asthma and cigarette smoking
Eur. Respir. J., November 1, 2004; 24(5): 822 - 833.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. I. Rennard
Antiinflammatory Therapies Other Than Corticosteroids
Proceedings of the ATS, November 1, 2004; 1(3): 282 - 287.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Laan, S. Bozinovski, and G. P. Anderson
Cigarette Smoke Inhibits Lipopolysaccharide-Induced Production of Inflammatory Cytokines by Suppressing the Activation of Activator Protein-1 in Bronchial Epithelial Cells
J. Immunol., September 15, 2004; 173(6): 4164 - 4170.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. C. Grootendorst and K. F. Rabe
Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. D. Sin, F. A. McAlister, S. F. P. Man, and N. R. Anthonisen
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
JAMA, November 5, 2003; 290(17): 2301 - 2312.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.